A phase II trial of deoxyspergualin in recurrent squamous cell head and neck cancer Journal Article
| Authors: | Pfister, D. G.; Bajorin, D.; Motzer, R. J.; Scher, H.; Louison, C.; Harrison, L.; Shah, J.; Strong, E.; Bosl, G. |
| Article Title: | A phase II trial of deoxyspergualin in recurrent squamous cell head and neck cancer |
| Abstract: | Fifteen patients with recurrent squamous cell head and neck cancer were treated with deoxyspergualin. There were no objective responses in 14 evaluable patients. The most common toxicity was reversible hypotension, which prompted dose reduction in nine patients. Deoxyspergualin is not recommended for the treatment of squamous cell head and neck cancer. |
| Keywords: | head and neck cancer; deoxyspergualin |
| Journal Title: | Investigational New Drugs |
| Volume: | 11 |
| Issue: | 1 |
| ISSN: | 0167-6997 |
| Publisher: | Springer |
| Date Published: | 1993-02-01 |
| Start Page: | 53 |
| End Page: | 56 |
| Language: | English |
| ACCESSION: | WOS:A1993LF64700008 |
| DOI: | 10.1007/bf00873911 |
| PROVIDER: | wos |
| PUBMED: | 8349436 |
| Notes: | Article -- Source: Wos |
